Catalyst Wire Dossier Catalyst Wire Dossier

Plasmodium vivax CSP-derived synthetic peptides

· Malaria Vaccine and Drug Development Center
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Plasmodium vivax CSP-derived synthetic peptides, covering 2010-03-08 to 2010-03-08. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Immunogenicity Study of Plasmodium Vivax CS Derived Synthetic Peptides Formulated in Two Adjuvants [Phase 1]

See pricing